2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Puritas ≥99.0% Pirfenidone media Factory

Description:

Nomen chemicum: 2-Hydroxy-5-Methylpyridine

Synonyma: 5-Methyl-2(1H)-Pyridinone

CAS: 1003-68-5

Puritas: ≥99.0%

Aspectus: Off-White ad Yellow Crystalline pulveris

Medium Pirfenidone (CAS: 53179-13-8) tractare fibrosis pulmonis idiopathici (IPF)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple, Puritas, Commercial Productio
Nomen chemicum: 2-Hydroxy-5-Methylpyridine
CAS: 1003-68-5

Chemical Properties:

Nomen chemicum 2-Hydroxy-5-Methylpyridine
Synonyma 5-Methyl-2(1H)-Pyridinone;2-Hydroxy-5-Picoline;6-Hydroxy-3-Picoline;5-Methyl-2-Pyridinol
CAS Number 1003-68-5
CATTUS Number RF-PI549
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C6H7NO
M. Pondus 109.13
Liquescens punctum 183.0 ad 187.0℃ (lit.)
Solubilitas Solutum in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Off-White ad Yellow Crystalline pulveris
Puritas ≥99.0%
Humor Content (KF) ≤0.50%
Residere in Ignition ≤0.50%
Unam immunditiam ≤0.50%
Totalis immunditias ≤1.00%
RELICTUM Solvents
n-Butanol ≤0.30%
Ethanol ≤0.30%
Test Standard Enterprise Standard
Consuetudinem Medium Pirfenidone (CAS: 53179-13-8)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

2-Hydroxy-5-Methylpyridinum (CAS: 1003-68-5) adhibetur ut intermedium pharmaceuticum Pirfenidone (CAS: 53179-13-8).Pirfenidone (PFD) est novum pyridinis genus ketonum, quod effectum latum spectrum anti-fibroticum habet, formationem fibrosis et scari praevenire et invertere valens.Shionogi in forum iniit, Iaponia in 2008 et ab US cibi et medicamenti Administrationis probatus est.Primum medicamentum est quod per periodum III tentationes clinicas abiit (inclusa iteratio, randomizatio et imperium placebo) quod efficaciam suam ostendit in fibrosis pulmonis idiopathicis tractandis (IPF);medicamentum autem bonum habet efficaciam relativam in curandis quibusdam morbis fibroticis sicut fibrosis renum interstitialibus et fibrosis hepatis.

Epistulam tuam hic scribe et mitte nobis